Company Search:
Advanced Search
Sponsored Links
Tempo Australia Limited Company Snapshot
Tempo Australia Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tempo Australia Limited with three other companies in this sector in Australia: Mesoblast Ltd (2015 sales of 23.75 million Australian Dollars [US$18.34 million] of which 100% was Mesenchymal Precursor Cell), Pharmaxis Ltd (58.63 million Australian Dollars [US$45.27 million] of which 69% was New Drug Development), and Xrf Scientific Ltd (20.67 million Australian Dollars [US$15.96 million] of which 44% was Precious Metals).

Sales Analysis. Sales increased substantially in 2015: During the year ended December of 2015, sales at Tempo Australia Limited were A$79.15 million (US$61.12 million). This is an increase of 393.5% versus 2014, when the company's sales were A$16.04 million. This was the fifth consecutive year of sales increases at Tempo Australia Limited (and since 2010, sales have increased a total of 2,824,802%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tempo Australia Limited
  Stock Performance Chart for Tempo Australia Limited
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): .25
(Figures in Australian Dollars)
1 Week -5.8%   13 Weeks -5.8%  
4 Weeks 2.1%   52 Weeks 191.7%  
Tempo Australia Limited Key Data:
  Ticker: TPP Country: Australia
  Exchanges: Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 79,153,753
(Year Ending Jan 2016).
Employees: N/A
  Currency: Australian Dollars Market Cap: 49,452,850
  Fiscal Yr Ends: December Shares Outstanding: 201,848,366
  Share Type: Ordinary Closely Held Shares: 111,479,608
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.